Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Lung Neoplasms

Gastroesophageal Adenocarcinoma

Cholangiocarcinoma

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms, Small Cell Lung Carcinoma

Limited Stage Small Cell Lung Cancer

Carcinoma, Hepatocellular, Cholangiocarcinoma

Lung Neoplasms

Carcinoma, Hepatocellular

Small Cell Lung Carcinoma

Fibrolamellar hepatocellular carcinoma, Carcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Hepatocellular, Liver Neoplasms

Adenocarcinoma, Stomach Neoplasms

Biliary Tract Neoplasms

Lung Neoplasms

Advanced Biliary Tract Carcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular, Liver Cirrhosis

Extensive Stage Small Cell Lung Cancer

Brain Neoplasms, Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Non Small Cell Lung Cancer NSCLC

Urinary Bladder Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Carcinoma, Hepatocellular

Non-small-cell Lung Cancer Patients

Cholangiocarcinoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Cholangiocarcinoma

Leukemia, Lymphocytic, Chronic, B-Cell

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

Mesothelioma

Adenocarcinoma of Lung, Lung Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Liver Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Neoplasm Metastasis

Biliary Tract Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Small Cell Lung Carcinoma

Carcinoma, Hepatocellular

Lung Neoplasms

Clinical Trials

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

I-SPY

REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

HAIC-quad

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

TIGOS-LS

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

ALICE

SG and Immunotherapy as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

TACTIC

NOVOCURE

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

SOLARA

CONCORDE

AUSTRAL

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

DIAMOND

ZENOBIA

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Proton-STRIDE

SIRT With Tremelimumab and Durvalumab for Resectable HCC

ATRiBRAVE

PHOENIX

MOST plus

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

DURVALUNG

Photon-STRIDE

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

MINUTE